<code id='94C2CA9C63'></code><style id='94C2CA9C63'></style>
    • <acronym id='94C2CA9C63'></acronym>
      <center id='94C2CA9C63'><center id='94C2CA9C63'><tfoot id='94C2CA9C63'></tfoot></center><abbr id='94C2CA9C63'><dir id='94C2CA9C63'><tfoot id='94C2CA9C63'></tfoot><noframes id='94C2CA9C63'>

    • <optgroup id='94C2CA9C63'><strike id='94C2CA9C63'><sup id='94C2CA9C63'></sup></strike><code id='94C2CA9C63'></code></optgroup>
        1. <b id='94C2CA9C63'><label id='94C2CA9C63'><select id='94C2CA9C63'><dt id='94C2CA9C63'><span id='94C2CA9C63'></span></dt></select></label></b><u id='94C2CA9C63'></u>
          <i id='94C2CA9C63'><strike id='94C2CA9C63'><tt id='94C2CA9C63'><pre id='94C2CA9C63'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:82766
          Matts Take Column Illustration
          Molly Ferguson for STAT

          American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

          Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

          advertisement

          How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          ActiGraph execs on goal of drug approvals with digital endpoints
          ActiGraph execs on goal of drug approvals with digital endpoints

          JeremeyWyattActiGraphAsdrugmakerswadeintousingdigitalhealthtechnologies,ActiGraphhasmadeitsmissionto

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Biogen joins immunology wave with $1.15 billion acquisition of HI

          RubyWallauforSTATBiogenisjoiningtheindustry’sfervoroverimmuneandinflammatorydiseasedrugdevelopmentwi